Waters' Q2 Revenues Inch up But Miss Analyst Estimates | GenomeWeb

Waters' Q2 Revenues Inch up But Miss Analyst Estimates

Jul 24, 2012

|

NEW YORK (GenomeWeb News) – Waters today said that revenues for the second quarter inched up 1 percent, as the firm missed analyst estimates on the top line.

For the three months ended June 30, the firm posted revenues of $451.5 million, up just under 1 percent from $447.6 million for the second quarter of 2011, but missing Wall Street expectations of $458.4 million. Its organic growth for the quarter was 4 percent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Breaking News

The Scan

Try the Other Version

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

You Do Your Way

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

CRISPR Discussions

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

This Week in Science

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.